CFCThe Compounder Score
AIRS logo

AIRS — AirSculpt Technologies, Inc.

Medical Care FacilitiesHealthcare

$0.84

+$0.12 (+16.23%)

AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure.

Market Cap

$61.88M

Forward P/E

-6.4x

52-Week Range

N/A

AIRS Price History

No cached price history available for this ticker yet.

Revenue vs. Net Income

$152M

Revenue · FY2025

Annual. Net margin is shown under each year.

RevenueNet income (green profit, red loss)

Free Cash Flow

$692K

FCF · FY2025

Annual. FCF margin is shown under each year.

Return on Capital Employed (ROCE)

-7.3%

ROCE · FY2025

Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.

Total Assets vs. Total Liabilities

1.9x

Assets ÷ liabilities · FY2025

Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.

Total assetsTotal liabilities

CapEx as % of Revenue

1.6%

CapEx · FY2025

Annual. Green at or under the 5% maximum target, red above it.

Shares Outstanding

+4.8%

Dilution · FY2025

Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).